Preliminary 1 week results COVID-19 BTN Study

Preliminary results from the
COVID-19 Back-to-Normal research study

REGISTERED IN CLINICALTRIALS.GOV

HTTPS://CLINICALTRIALS.GOV/CT2/SHOW/NCT04832932
PROTOCOL #20210103MEBO

Survey in English
eConsent in English
Survey en español
Conentimiento electrónico en español
See above-noted documents for privacy commitments

One week after MEBO launched this study, our MEBO Scientific Director and Founder of Aurametrix, Irene Gabashvili, PhD, writes her first post in her Aurametrix Blog about the preliminary results based on the responses to the survey of the 24 member of the MEBO community and 6 of their family members from various countries around the world. The responses refers to reactions to the Astrazeneca, J&J, Moderna, Pfizer and Sinovac/Coronavac vaccines, documenting the reactions sufferers of breath and body odor have experienced.

Urine and axillary odor are becoming slightly more aversive in healthy humans, as a function of immune activation. But this is not supposed to last too long… Interestingly, Pfizer vaccine that caused no or very mild reactions in several MEBO participants, was also the vaccine that possibly caused temporary worsening of odor symptoms in one person in the community. Another MEBO participant that reported possible worsening of odor from Moderna vaccine had one thing in common with the other individual - they both had pre-existing conditions related to their upper digestive tract. Some Astrazeneca recipients also reported odor issues but did not think it was worse than usual…We'll be posting more observations and comparisons with over 600 participants of our study from other communities.

I [Irene] have a lot of data now on bad adverse reactions to vaccines, so I can answer any questions to those who are still hesitant.

These are just very preliminary results, of course, only one week into the study, and the goal is to ultimately compare them to other communities of persons who do not suffer from odor conditions to determine whether there may be any significant differences.

Irene requests the following from us:

1. It would be interesting to know if we had more cases of (possible) COVID infections in the group.
2. We can accept people's stories as e-mails or PMs to maria.delatorre@meboresearch.org or irene.gabashvili@meboresearch.org
.
3. It's OK to skip some questions in the survey.
4. Even if you were never vaccinated, you are welcome to share your observations about COVID infections or how they avoided COVID.

Message to our community from Irene:

I have a lot of data now on bad adverse reactions to vaccines, so I can answer any questions to those who are still hesitant. irene.gabashvili@meboresearch.org. I mean, I agree that some people should be very careful about vaccination as certain pre-existing conditions could cause really bad reactions. Even more so if infected. It's better to know what to expect and to be prepared.

Thank you, Irene for all you do for us on a pro-bono basis. Your dedication to our MEBO community around the world is greatly appreciated beyond words!

María

María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.meboafrica.org
www.meboresearch.co.uk
MEBO's Blog (English)
El Blog de MEBO (español)

A EURORDIS and NORD Member Organization